Role of some Hematological and Immunological Parameters in Pathogenesis of Ankylosing Spondylitis in a Sample of Iraqi Male Patients.

Sumyah H. Hassan; Ekhlass N. Ali; Ibtesam G. Auda; Mohammed Hadi Munshed Al-Osami

doi:10.47419/bjbabs.v5i2.300

Authors

Sumyah H. Hassan Mustansiriyah University, College of Science, Department of Biology, Baghdad, Iraq https://orcid.org/0009-0008-9455-0615
Ekhlass N. Ali Mustansiriyah University, College of Science, Department of Biology, Baghdad, Iraq https://orcid.org/0000-0001-9402-6153
Ibtesam G. Auda Mustansiriyah University, College of Science, Department of Biology, Baghdad, Iraq https://orcid.org/0000-0003-1658-6715
Mohammed Hadi Munshed Al-Osami Baghdad Teaching Hospital/Ministry of Health/Baghdad, Iraq https://orcid.org/0000-0001-8521-5876

DOI:

https://doi.org/10.47419/bjbabs.v5i2.300

Keywords:

Ankylosing spondylitis (AS), C-reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), Magnetic Resonance Imaging (MRI), Receiver Operating Characteristics (ROC)

Abstract

Ankylosing spondylitis (AS) is an autoimmune disease that is chronic, systemic seronegative inflammatory spondyloarthropathy. Magnetic resonance imaging (MRI) was used in the diagnosis of AS patients, as well as other clinical and laboratory criteria like symptoms and elevated levels of ESR and C-reactive protein. The current study intends to establish the role of certain hematological and immunological factors in the development of AS and to analyze the connections between these indicators. The methods of work included blood sample collection from 100 participants (50 AS male patients and 50 healthy controls). The ages of both groups were between 20-60 years. Two milliliters of blood were used for CBC (Hb and WBC) and ESR analysis, while three milliliters of the blood were put in a gel tube to measure serum levels of CRP, IL-17, and IL-22 using the ELISA technique. It shows that the AS was most prevalent in the age range of 20-35 years (p = 0.013). There was a highly significant increase (p<0.001) in, ESR, CRP, IL17, and IL22 in AS patients as a result of inflammation compared to controls, while the Hb is significantly raised in the control group as compared with patients and except for the WBC level that was non-significant. The WBC was a non-specific parameter associated with AS development, while AS patients have lower Hb and increased levels of CRP, ESR, IL17, and IL22 that were excellent biomarkers for the diagnosis of AS they were all greater in AS patients than in healthy controls, and they might be recommended as a predictive measure for AS patients.

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Wenker KJ, Quint JM. Ankylosing Spondylitis. and others, editor. Treasure Island (FL), StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK470173.

Fadhil HR, Al-Jumaili AA, Ani NAA. Comparison between Reference Infliximab (Remicade) and its Biosimilar (Remsima) in Patients with Ankylosing Spondyli- tis: A Field-based Pharmacoeconomic Study. Al-Kindy College Medical Journal . 2023;19(1):100–105. https://doi.org/10.47723/kcmj.v19i1.908.

Al_Azawi SA, Muhamad I. Adoption of Geometric Properties to Detect Herniated Spinal Disc of Human. Ma’ulūm al-mustans.iriyyaAl-Mustansiriyah Journal of Science . 2017;28(3):187–92. doi.org/10.23851/mjs.v28i3.38.

Jassim AS, Ali EN, Auda IG, Al-osami MHM. Role of some Immunological and non-Immunological Parameters in Prognosis and diagnosis of Systemic lupus erythematosus in Iraqi women patients . Al-Mustansiriyah Journal of Science . 2023;34(4):29–36. DOI: https://doi.org/10.23851/mjs.v34i4.1363.

Schinocca C, Rizzo C, Fasano S, Grasso G, Barbera L, Ciccia L, et al.; 2021. Available from: https://doi.org/10.3389/fimmu.2021.637829.

Wilbrink R, Spoorenberg A, Verstappen G, Kroese F. B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis. International Journal of Molecular Sciences. 2021;22(24):13325–13325. https://doi.org/10.3390/ijms222413325.

Muhsin HY, Rasha MA, Al-Humairi, Duraid QJ, Alshareef; 2022. Available from: https://doi.org/10.1016/j.ejr.2022.07.002.

Toussirot E, Laheurte C, Gaugler B, Gabriel D, Saas P; 2018. Available from: https:

//doi.org/10.3389/fimmu.2018.01610.

Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X. Ankylosing spondylitis: etiology, pathogenesis, and Treatments. vol. 7. Bone Research; 2019. Available from: https:

//doi.org/10.1038/s41413-019-0057-8.

liang Li MD L, MD JF, MD CX, MD MN, MD WC, bo Hao MD L, et al. Gen- der Differences in Ankylosing Spondylitis Patients with Advanced Hip Involve- ment: Results from A Matched Retrospective Cohort Study. Gender Differences in Ankylosing Spondylitis Patients with Advanced Hip Involvement: Results from A Matched Retrospective Cohort Study Orthopaedic Surgery. 2021;14:405–415. https://doi.org/10.1111/os.13123.

Zviahina O, Shevchuk S, Pavliuk O. The role of hepcidin in the formation of anemical syndrome in patients with ankylosing spondylitis and its significance in the differentiation of anemia of chronic disease, iron deficiency anemia and their combination. Annals of the Rheumatic Diseases. 2023;82(1):1755–1757. https://doi.org/10.1136/annrheumdis-2023-eular.3852.

Zhu L, Zhou S, Lin Y, Ye Z, Tang Y, Chen R. Changes in C-reactive protein, ery- throcyte sedimentation rate, human leukocyte antigen-B27, and immunoglobulins A, G, M in patients with ankylosing spondylitis. Romanian Journal of Laboratory Medicine. 2023;31(2):113–118. https://doi.org/10.2478/rrlm-2023-0012.

Zviahina OV, Shevchuk SV, Kuvikova IP, Segeda IS. Anemia in patients with ankylosing spondylitis, association with the activity of the inflammatory pro- cess and the severity of the disease. vol. 73. Warsaw Poland; 2020. DOI: 10.36740/WLek202004117.

Shevchuk SV, Zviahina OV, Zviahin OS, Bezsmertnyi YO, Segeda IS, Bezsmertnyi. Quality of life in patients with ankylosing spondylitis with anemic syndrome assessed according to the ASQoL questionnaire, the relationship with the course of the dis- ease. 2022;12:52–58. DOI: https://doi.org/10.22141/pjs.12.2.2022.329.

Lata M, ASH, ju Liu C. Targeting tumor necrosis factor receptors in ankylos- ing spondylitis. Annals of the New York Academy of Sciences. 2018;15(1):5–16. https://doi.org/10.1111/nyas.13933.

Gökmen F, Akbal A, Reşorlu H, Gökmen E, Güven M, Aras AB, et al. Neutrophil- Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis. Journal of Clinical Laboratory Analysis. 2015;29(4):294– 298. https://doi.org/10.1002/jcla.21768.

Reveille JD. Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clinical Rheuma- tology. 2015;34(6):1009–1027. https://doi.org/10.1007/s10067-015-2949-3.

Su J, Cui L, Yang W, Shi H, Jin C, Shu R, et al. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study. vol. 14. YM F, editor; 2019. https://doi.org/10.1371/journal.pone.0211946.

Al-Ubadi AE. A Comparative Study between C-Reactive Protein and Procalcitonin in Iraqi Burn Patients. Al-Mustansiriyah Journal of Science. 2017;28:41–41. DOI: https://doi.org/10.23851/mjs.v28i1.310.

Kuwabara TK, Ishikawa F, Kondo M, Kakiuchi T. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases. Mediators of Inflammation. 2017;2017:1–11. https://doi.org/10.1155/2017/3908061.

Wielińska J, Świerkot J, Kolossa K, Bugaj B, Chaszczewska-Markowska M, Jeka S; 2021. Available from: https://doi.org/10.1155/2021/3125922.

ALKAN H, YILDIZ N, ARDIÇ F. The Correlations Between Disease Specific Quality of Life, Short Form-36 and Clinical Variables in Patients With Ankylosing Spondyli- tis. Archives of Rheumatology. 2020;35(4):468–476. doi: 10.46497/ArchRheuma- tol.2020.7750.

Jürgen B, Désirée H, Mittie K, Doyle, Chenglong H, Atul D, et al. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab. Arthritis & Rheumatism. 2009;61(8):1032–1036. https://doi.org/10.1002/art.24865.

Aydemir FD, Can G, Uslu S, Kenar G, Birlik M, Önen F. Evaluation of Acute Phase Reactants in Patients with. Journal of Contemporary Medicine. 2022;12(6):846–850. https://doi.org/10.16899/jcm.1154860.

Liang T, Chen J, Xu G, Zhang Z, Xue J, Zeng H, et al. Platelet-to- Lymphocyte Ratio as an Independent Factor Was Associated With the Severity of Ankylosing Spondylitis. Frontiers in Immunology. 2021;12:760214–760214. https://doi.org/10.3389/fimmu.2021.760214.

jixiang D, Shanshan X, Xing G, Shengqian X, Zongwen S, Faming, et al. Red Cell Dis- tribution Width and Mean Platelet Volume in Patients With Ankylosing Spondyli- tis: A Systematic Review and Meta-analysis. Jcr-journal of Clinical Rheumatology. 2021;27(7):292–297. doi: 10.1002/ART.24865.